Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

GlaxoSmithKline strikes back over anti-ageing pills

Drugs do work as thought, says pharmaceutical giant.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. Dai, J. et al. J. Biol. Chem. advance online publication doi:10.1074/jbc.M110.133892 (2010)

  2. Kaeberlein, M. et al. J. Biol. Chem. 280, 17038-17045 (2005).

    Article  Google Scholar 

  3. Beher, D. et al. Chem. Biol. Drug. Des. 74, 619-624 (2009).

    Article  Google Scholar 

  4. Pacholec, M. et al. J. Biol. Chem. 285, 8340-8351 (2010).

    Article  Google Scholar 

  5. Baur, J. et al. Nature 444, 337-342 (2006).

    Article  ADS  Google Scholar 

  6. Milne, J. C. et al. Nature 450, 712-716 (2007).

    Article  ADS  Google Scholar 

Download references


Related links

Related links

Related external links

Sirtris Pharmaceuticals

Ronen Marmorstein

Joseph Bauer

Matt Kaeberlein

Healthy Lifespan Institute

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Callaway, E. GlaxoSmithKline strikes back over anti-ageing pills. Nature (2010).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research